CN Patent

CN101505752A — 脯氨酸羟化酶抑制剂

Assigned to SmithKline Beecham Corp · Expires 2009-08-12 · 17y expired

What this patent protects

本发明在此涉及式(I)的具体的嘧啶三酮N－取代的甘氨酸衍生物，其为HIF脯氨酸羟化酶的拮抗剂，以及其用于治疗受益于抑制此酶的疾病，例如贫血症。

USPTO Abstract

本发明在此涉及式(I)的具体的嘧啶三酮N－取代的甘氨酸衍生物，其为HIF脯氨酸羟化酶的拮抗剂，以及其用于治疗受益于抑制此酶的疾病，例如贫血症。

Drugs covered by this patent

Patent Metadata

Patent number
CN101505752A
Jurisdiction
CN
Classification
—
Expires
2009-08-12
Drug substance claim
No
Drug product claim
No
Assignee
SmithKline Beecham Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.